Colorectal cancer prevention: The role of prebiotics

Handbook of Prebiotics

Volumn , Issue , 2008, Pages 285-294

  Asad, Umar ^a   Emenaker, Nancy J ^a   Milner, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858286017     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (53)

1. Lock, K. et al., The global burden of disease attributable to low consumption of fruit and vegetables: Implications for the global strategy on diet, Bull. World Health Organ., 83, 100,2005.
2. Bray, G. A. and Bellanger, T., Epidemiology, trends, and morbidities of obesity and the metabolic syndrome, Endocrine, 29, 109, 2006.
3. Jemal, A. R. et al., Cancer statistics, CA Cancer J. Clin., 57,43,2007.
4. World Cancer Research Fund, American Institute for Cancer Research, Food, Nutrition and the Prevention of Cancer: A Global Perspective, American Institute for Cancer Research, Washington, DC, 1997.
5. Davis, C.D. and Milner J., Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention, Mutat. Res., 551, 51, 2004.
6. Tajima, K. and Kuriki, K., The increasing incidence of colorectal cancer and the preventive strategy in Japan, Asian Pac. J. Cancer Prev., 7,495, 2006.
7. Calle, E.E. and Thun, M.J., Obesity and cancer, Oncogene, 23, 6365, 2004.
8. Larsen, I.K. et al., Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals, BMC Gastroenterol., 13, 6, 2006.
9. Divisi, D. et al., Diet and cancer, Acta Biomed., 77, 118, 2006.
10. Davis, C.D., Nutritional interactions: Credentialing of molecular targets for cancer prevention, Exp. Biol. Med., 232, 176, 2007.
11. Forman, M. R. et al., Nutrition and cancer prevention: A multidisciplinary perspective on human trials, Annu. Rev. Nutr., 24, 223, 2004.
12. Vogelstein, B. et al., Genetic alterations during colorectal-tumor development, N. Engl. J. Med, 319, 525, 1988.
13. Fearon, E. R. and Vogelstein, B., A genetic model for colorectal tumorigenesis, Cell, 61, 759,1990.
14. Fearon, E. R., Human cancer syndromes: Clues to the origin and nature of cancer, Science, 278, 1043, 1997.
15. Sjoblom, T. et al., The consensus coding sequences of human breast and colorectal cancers, Science, 314, 268, 2006.
16. Papas, M. A. et al., Fiber from fruit and colorectal neoplasia, Cancer Epidemiol. Biomarkers Prev., 13, 1267,2004.
17. Ahmed, F. E., Gene-gene, gene-environment & multiple interactions in colorectal cancer, J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev., 24,1, 2006.
18. Roncucci, L. et al., Classification of aberrant crypt foci and microadenomas in human colon, Cancer Epidemiol. Biomarkers Prev., 1, 57, 1991.
19. Wargovich, M. J. et al., Aberrant crypts as a biomarker for colon cancer: Evaluation of potential chemopreventive agents in the rat, Cancer Epidemiol. Biomarkers Prev., 5, 355,1996.
20. Rudolph, R. E. et al., Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans, Cancer Epidemiol. Biomarkers Prev., 14, 605, 2005.
21. Pretlow, T. P. et al., Aberrant crypts: Putative preneoplastic foci in human colonic mucosa, Cancer Res., 51,1564, 1991.
22. Roncucci, L. et al., Identification and quantification of aberrant crypt foci and microadenomas in the human colon Hum Pathol 99 987 1991
23. Takayama, T. et al., Aberrant crypt foci of the colon as precursors of adenoma and cancer, N. Engl. J. Med, 339,1277, 1998.
24. Takayama, T. et al., Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis, Gastroenterology, 121, 599,2001.
25. Makinen, M.J., Colorectal serrated adenocarcinoma, Histopathology, 50, 131, 2007.
26. Kimura, N. et al., Methylation profiles of genes utilizing newly developed CpG island methylation microarray on colorectal cancer patients, Nucleic Acids Res., 10,46,2005.
27. Greenspan, E.J. et al., Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer, Carcinogenesis, e-prepublication, November 4, 2006.
28. Nagasaka, T. et al., Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation, J. Clin. Oncol., 22, 4584, 2004.
29. Shike, M., Diet and lifestyle in the prevention of colorectal cancer: An overview, Am. J. Med, 106,11S, 1999.
30. Campos, F. G. et al., Diet and colorectal cancer: Current evidence for etiology and prevention, Nutr. Hosp., 20,18, 2005.
31. Roberfroid, M., Dietary fiber, inulin, and oligofructose: A review comparing their physiological effects, Crit. Rev. Food Sci. Nutr., 33, 103,1993.
32. Roberfroid, M. B., Functional foods: Concepts and application to inulin and oligofructose, Br. J. Nutr., 87, S139,2002.
33. Roberfroid, M. B., Introducing inulin-type fructans, Br. J. Nutr., 93, S13, 2005.
34. Wactawski-Wende, J. et al., Calcium plus vitamin D supplementation and the risk of colorectal cancer, N. Engl. J. Med., 354, 684, 2006.
35. Lee, I.M. et al., Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial, JAMA, 294, 56, 2005.
36. Grau, M.V. et al., Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized tria, J. Natl. Cancer Inst., 99, 129, 2007.
37. Young, G.P. and Le Leu, R.K., Resistant starch and colorectal neoplasia, J. AOAC Int., 87, 775, 2004.
38. Pool-Zobel, B.L., Inulin-type fructans and reduction in colon cancer risk: Review of experimental and human data, Br. J. Nutr., 93, S73, 2005.
39. Lim, C.C., Ferguson, L.R. and Tannock, G.W., Dietary fibres as "prebiotics": Implications for colorectal cancer, Mol. Nutr. Food Res., 49, 609, 2005.
40. Hudson, T.S. et al., Dietary fiber intake: Assessing the degree of agreement between food frequency questionnaires and 4-day food records, J. Am. Coll. Nutr., 25, 370, 2006.
41. Bingham, S., The fibre-folate debate in colo-rectal cancer, Proc. Nutr. Soc., 65,19, 2006.
42. Schatzkin A, Lanza E; Polyp Prevention Trial Study Group, Polyps and vegetables (and fat, fibre): The polyp prevention trial, IARC Sci. Publ., 156, 463, 2002.
43. Hartman, T.J. et al., Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas? Cancer Enidemiol, Biomarkers Prev. 14, 2359, 2005.
44. Hughes, R. and Rowland, I. R., Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon, Carcinogenesis, 22, 43, 2001.
45. Rowland, I. R. et al., Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats, Carcinogenesis, 19, 281,1998.
46. Wong, J.M. et al., Colonic health: Fermentation and short chain fatty acids, J. Clin. Gastroenterol., 40, 235, 2006.
47. Comalada, M. et al., The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype, J. Cancer Res. Clin. Oncol., 132,487, 2006.
48. Cai, J. et al., Overexpression of heat shock factor 1 inhibits butyrate-induced differentiation in colon cancer cells, Cell Stress Chaperones, 11, 199, 2006.
49. Shureiqi, I. et al., The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer, FASEB J., 21, 743, 2007.
50. Kiefer, J., Beyer-Sehlmeyer, G. and Pool-Zobel, B.L., Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells, Br. J. Nutr., 96, 803, 2006.
51. Van Loo, J. et al., The SYNCAN project: goals, set-up, first results and settings of the human intervention study, Br. J. Nutr., 93, S91,2005.
52. Rafter, J. et al., Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients, Am. J. Clin. Nutr., 85, 488,2007.
53. Van Loo, J. and Jonkers, N., Evaluation in human volunteers of the potential anticarcinogenic activities of novel nutritional concepts: prebiotics, probiotics and synbiotics (the SYNCAN project QLK1-1999-00346), Nutr. Metab. Cardiovasc. Dis, 11,87,2001.